Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPE | Q05469 | 6/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluazifop SCHEMBL9789176 | 0.95 | LIPE (0.49) | LIPEL3MBTL1FFAR1LMNAKMT2A | |
| SCHEMBL9160106 | 0.91 | LIPE (0.50) | LIPEL3MBTL1FFAR1LMNAKMT2A | |
| Fluazifop SCHEMBL67403 | 0.87 | LMNA (0.62) | LIPELMNASMN1; SMN2RAB9A | |
| Fluazifop-P SCHEMBL118853 | 0.87 | LMNA (0.62) | LIPELMNASMN1; SMN2RAB9A | |
| Fluazifop SCHEMBL1559717 | 0.87 | LMNA (0.62) | LIPELMNASMN1; SMN2RAB9A | |
| Fluazifop-P SCHEMBL29370487 | 0.87 | LMNA (0.62) | LIPELMNASMN1; SMN2RAB9A | |
| Fluazifop SCHEMBL29370478 | 0.87 | LMNA (0.62) | LIPELMNASMN1; SMN2RAB9A | |
| Fluazifop SCHEMBL1010239 | 0.87 | LMNA (0.62) | LIPELMNASMN1; SMN2RAB9A | |
| Fluazifop SCHEMBL7576720 | 0.86 | TDP1 (0.60) | LIPEL3MBTL1FFAR1LMNAKMT2A | |
| Fluazifop-P SCHEMBL11006621 | 0.85 | LMNA (0.60) | LIPELMNASMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0353248-B1 | METHOD FOR RESOLUTION OF STEREOISOMERS IN MULTIPHASE AND EXTRACTIVE MEMBRANE REACTORS | SEPRACOR INC (US) | 1995-03-29 | — | — | EP | disclosed |
| EP-0353248-A4 | METHOD FOR RESOLUTION OF STEREOISOMERS IN MULTIPHASE AND EXTRACTIVE MEMBRANE REACTORS | — | 1991-07-17 | — | — | EP | disclosed |
| EP-0353248-A1 | METHOD FOR RESOLUTION OF STEREOISOMERS IN MULTIPHASE AND EXTRACTIVE MEMBRANE REACTORS. | SEPRACOR INC (US) | 1990-02-07 | — | — | EP | disclosed |
| US-4800162-A | ENZYME-ACTIVATED MEMBRANE | SEPRACOR, INC. (US) | 1989-01-24 | — | — | US | disclosed |
| WO-1988007582-A1 | METHOD FOR RESOLUTION OF STEREOISOMERS IN MULTIPHASE AND EXTRACTIVE MEMBRANE REACTORS | SEPRACOR, INC. (US) | 1988-10-06 | — | — | WO | disclosed |